DNTH · Dianthus Therapeutics, Inc. /DE/
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements were issued (the "issuance date") As of the issuance date, the Company expects that its existing cash, cash equivalents and investments on hand will be sufficient to fund its obligations as they become due for at least twelve months beyond the issuance date.”View the 10-Q filed Aug 4, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-19 | Read Simon |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
2,778 |
| 2026-08-19 | Read Simon |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. |
Common Stock
|
2,778 |
| 2026-08-19 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.01 to $117.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
2,778 |
| 2026-08-13 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↑
|
Common Stock
|
15,000 |
| 2026-08-13 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares of common stock underlying this stock option award vested as to 25% of the shares on June 20, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
15,000 |
| 2026-08-10 | McGeorge Anne |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.79 to $107.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
1,450 |
| 2026-08-10 | Read Simon |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. |
Common Stock
|
2,777 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.54 to $108.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
737 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.55 to $110.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
272 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.54 to $109.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
831 |
| 2026-08-10 | Read Simon |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
2,777 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.50 to $107.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
70 |
| 2026-08-10 | McGeorge Anne |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. |
Stock Option (Right to Buy)
|
1,250 |
| 2026-08-10 | McGeorge Anne |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. |
Common Stock
|
6,500 |
| 2026-08-10 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
16,167 |
| 2026-08-10 | McGeorge Anne |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.05 to $111.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
1,000 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.56 to $111.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
470 |
| 2026-08-10 | McGeorge Anne |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.15 to $111.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
700 |
| 2026-08-10 | McGeorge Anne |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.89 to $109.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
1,800 |
| 2026-08-10 | Read Simon |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.57 to $111.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
397 |
| 2026-08-10 | McGeorge Anne |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. |
Stock Option (Right to Buy)
|
6,500 |
| 2026-08-10 | Veness Adam M |
SVP, General Counsel and Sec. |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.00 to $110.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
16,167 |
| 2026-08-10 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. |
Common Stock
|
16,167 |
| 2026-08-10 | McGeorge Anne |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. |
Common Stock
|
1,250 |
| 2026-08-10 | McGeorge Anne |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.84 to $108.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
2,800 |
| 2026-08-07 | Veness Adam M |
SVP, General Counsel and Sec. |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.08 to $111.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
616 |
| 2026-08-07 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. |
Common Stock
|
3,833 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.57 to $108.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
21,909 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.52 to $108.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Common Stock
|
104,091 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.68 to $108.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
23,907 |
| 2026-08-07 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
3,833 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.68 to $107.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
10,384 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
126,000 |
| 2026-08-07 | Veness Adam M |
SVP, General Counsel and Sec. |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.07 to $111.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
3,217 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. |
Common Stock
|
40,000 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Convert↑
|
Common Stock
|
126,000 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.74 to $109.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
2,373 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
40,000 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.75 to $110.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
2,536 |
| 2026-08-07 | Garcia Marino |
Director, CEO AND PRESIDENT |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026. |
Common Stock
|
800 |
| 2026-07-09 | Savitz Ryan |
EVP, CFO & CBO |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. |
Common Stock
|
31,249 |
| 2026-07-09 | Savitz Ryan |
EVP, CFO & CBO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.95 to $102.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
5,566 |
| 2026-07-09 | Savitz Ryan |
EVP, CFO & CBO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.75 to $100.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
10,354 |
| 2026-07-09 | Savitz Ryan |
EVP, CFO & CBO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
31,249 |
| 2026-07-09 | Savitz Ryan |
EVP, CFO & CBO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.78 to $101.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
15,329 |
| 2026-06-17 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. |
Common Stock
|
30,000 |
| 2026-06-17 | Veness Adam M |
SVP, General Counsel and Sec. |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.00 to $81.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
13,229 |
| 2026-06-17 | Veness Adam M |
SVP, General Counsel and Sec. |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
16,771 |
| 2026-06-17 | Veness Adam M |
SVP, General Counsel and Sec. |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
30,000 |
| 2026-06-01 | Randhawa Simrat |
EVP, Head of R&D |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.17 to $91.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
16,943 |